Internal Medicine Doctors in Itasca, IL Accepting Medicare

4 Internal Medicine doctors found. Showing 1 - 4

Dr. Richa Varma, MD Internal Medicine - Addiction Medicine Medicare: Accepting Medicare Assignments Practice Location: 1300 N Arlington Heights Rd Ste 130, Itasca, IL 60143 Phone: 847-871-4540    Fax: 630-246-6650

Dr. Rajeswar Rajagopalan, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1300 N Arlington Heights Rd Ste 130, Itasca, IL 60143 Phone: 847-871-4540    Fax: 847-871-4597

Joshua Robert Brownell, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1300 N Arlington Heights Rd Ste 130, Itasca, IL 60143 Phone: 847-871-4540    Fax: 847-871-4597

Dr. Muhammad Muzammil, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1300 N Arlington Heights Rd Ste 130, Itasca, IL 60143 Phone: 847-871-4540

News Archive

Red pepper consumption can help manage appetite

Spicing up your daily diet with some red pepper can curb appetite, especially for those who don't normally eat the popular spice, according to research from Purdue University.

Alnylam to present data on RNAi therapeutics for fibrotic diseases at The Liver Meeting

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today it will present several poster presentations at the 61st Annual Meeting of the American Association for the Study of Liver Diseases being held in Boston, Mass from October 29 - November 2, 2010.

Bivalirudin improves net clinical outcomes and increases survival in heart attack patients

A study led by Gregg W. Stone, M.D., professor of medicine at Columbia University Medical Center/NewYork-Presbyterian and chairman of the Cardiovascular Research Foundation, has shown that heart attack patients who were administered the direct thrombin inhibitor bivalirudin during primary angioplasty had a reduced rate of adverse clinical events, a lower rate of major bleeding, and a lower mortality rate than those who were treated with a regimen of heparin and glycoprotein IIb/IIIa inhibitors (GPI).

Golgi stress signaling pathway found in cells with Huntington's disease

Working with cells grown in the lab, Johns Hopkins researchers have identified a biochemical pathway that allows a structure within cells, called the Golgi apparatus, to combat stress caused by free radicals and oxidants.

Preclinical data for potent IDO pathway inhibitor presented at AACR 2013 annual meeting

NewLink Genetics Corporation, a biopharmaceutical company primarily focused on discovering, developing and commercializing immunotherapeutic products in oncology, announced today that the company presented preclinical data for NLG919, a potent IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor, at the American Association for Cancer Research 2013 annual meeting.

Read more Medical News

› Verified 5 days ago